Delivery Order SPE2DR25D7066-SPE2DR26F7ZPR
Award Date 12/23/25
Potential Completion Date 12/24/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,366.17 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 5, 2025, with completion expected by December 8, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $27,766.85 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,498.54 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of December 4, 2025. The award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and place of performance. This delivery order operates under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,371.93 delivery order for Ondansetron ODT 4 mg tablets (30-count) on November 28, 2025, with an ultimate completion date of December 1, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) valued at $13,512.62. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract was executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $1,121.22. This non-set-aside, firm fixed price contract was awarded on December 18, 2025, with an ultimate completion date of December 19, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,178.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 8, 2025, with completion scheduled for December 9, 2025. This contract is unset-aside and represents a competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $21,685.95. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competitive procurement. The order is due for completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $5,618.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,595.10 on December 16, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside provisions, consistent with...